首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1498628

生物分析测试服务市场规模、份额、成长分析、按分子、按测试、按工作流程、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

Bioanalytical Testing Services Market Size, Share, Growth Analysis, By Molecule, By Test, By Workflow, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年06月10日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年生物分析测试服务的市场规模将为24.2亿美元，预测期内（2024-2031年）复合年增长率为15%，从2023年的27.8亿美元增加到2031年的85亿美元。成长到美国1000万美元。

生物分析测试服务市场包括向製药和生技药品。这些服务包括测量生物体液和组织（例如血液、尿液和组织）中的药物、代谢物和生物标记浓度，对于药物开发和监管核准至关重要。例如，药明康德是生物分析自动化的早期采用者，将生产力提高了 400%。该市场由 CRO 和其他服务供应商组成，旨在提供高效、准确的测试来支持药物开发。开发和核准新药的需求是成长动力，但高成本和缺乏标准化方法是主要挑战。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Eurofins Scientific SE（Luxembourg）
Charles River Laboratories International, Inc.（US）
Laboratory Corporation of America Holdings（US）
WuXi AppTec（China）
PPD, Inc.（US）
Frontage Laboratories, Inc.（US）
SGS SA（Switzerland）
ICON plc（Ireland）
Intertek Group plc（UK）
Bioanalytical Systems, Inc.（US）
Almac Group（UK）
Anapharm（Canada）
Pharmaron Beijing Co., Ltd.（China）
Syneos Health（US）
Celerion（US）
BioAgilytix Labs（US）
Medpace Holdings, Inc.（US）
Bioclinica（US）
LGC Limited（UK）
PSI CRO AG（Switzerland）

简介目录

Product Code: SQMIG35D2157

Bioanalytical Testing Services Market size was valued at USD 2.42 Billion in 2022 and is poised to grow from USD 2.78 Billion in 2023 to USD 8.51 Billion by 2031, at a CAGR of 15 % during the forecast period (2024-2031).

The bioanalytical testing services market encompasses analytical services provided to pharmaceutical and biotech companies to assess the safety and efficacy of drugs and biologics in humans. These services, which include measuring drug, metabolite, and biomarker concentrations in biological fluids and tissues such as blood, urine, and tissue, are crucial for drug development and regulatory approval. For example, WuXi AppTec's early adoption of bioanalytical automation led to a 400% productivity increase. The market consists of CROs and other service providers, aiming to deliver efficient and accurate testing to support drug development. Growth is driven by the need for new drug development and approval, but high costs and lack of standardized methods pose significant challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioanalytical Testing Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioanalytical Testing Services Market Segmental Analysis

Bioanalytical Testing Services Market is segmented based on Molecule, Test, Workflow, Application, End User and region. By molecule, the market is segmented into small molecules and large molecules. By test, the market is segmented into ADME, Pharmacokinetics, Pharmacodynamics, Bioavailability, Bioequivalence, and Others. By Workflow, the market is segmented into Sample Preparation (Protein Precipitation, Liquid-Liquid Extraction, Solid Phase Extraction), Sample Analysis (Hyphenated technique, Chromatographic technique, Electrophoresis, Ligand Binding Assay, Mass Spectrometry, Nuclear Magnetic Resonance). By application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology, and others. By end users, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Contract Development and Manufacturing Organizations, and Contract Research Organizations. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Bioanalytical Testing Services Market

The increasing demand for personalized medicines is significantly boosting the bioanalytical testing services sector, which is crucial for developing and testing these tailored treatments. Bioanalytical testing is essential in assessing drug efficacy for individual patients, ensuring the selection of the most suitable treatment plans. For example, the global surge in cancer cases has driven the need for self-administered, forward-looking drugs, making this a highly profitable market. This focus on personalized cancer therapies has, in turn, accelerated the growth of the bioanalytical testing market by improving the effectiveness of cancer treatments through more precise and patient-specific drug evaluation.

Restraints in the Bioanalytical Testing Services Market

The bioanalytical testing market faces significant growth constraints due to a shortage of skilled personnel capable of managing advanced equipment requirements. This challenge is underscored by the projected 13% increase in demand for medical laboratory technicians between 2016 and 2026, highlighting a critical gap in workforce supply. Without sufficient skilled technicians, the adoption of new technologies and processes may be hindered, thereby limiting market expansion. As the industry evolves, this shortfall in expertise could pose substantial barriers, restricting the ability to fully leverage technological advancements and meet the growing needs of the bioanalytical testing sector.

Market Trends of the Bioanalytical Testing Services Market

Pharmaceutical companies are increasingly turning to third-party service providers for bioanalytical testing to cut costs, boost efficiency, and concentrate on their primary areas of expertise. This outsourcing trend is anticipated to grow in the foreseeable future. By partnering with specialized external firms, pharmaceutical companies can leverage advanced technologies and expert knowledge without the burden of maintaining extensive in-house laboratories. This strategic shift allows them to streamline operations, enhance productivity, and allocate more resources to drug development and innovation, thereby accelerating time-to-market for new therapies and responding more swiftly to evolving industry demands and regulatory requirements.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Patent Analysis
Pricing Analysis
Ecosystem of the Market
Start-up Analysis
Case Study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Bioanalytical Testing Service Market by Molecule

Small Molecule
Large Molecule
- Liquid Chromatography-Mass (LC-MS) Spectrometry
- Immunoassays
- Pharmacokinetics (PK)
- Anti-Drug Antibodies (ADA)
- Others
Others

Bioanalytical Testing Service Market by Test Type

Market Overview
ADME
- In-Vivo
- In-Vitro
Pharmacokinetic (PK)
Pharmacodynamics (PD)
Bioavailability
Bioequivalence
Other

Bioanalytical Testing Service Market by Workflow

Market Overview
Sample Preparation
- Protein Precipitation
- Liquid-Liquid Extraction
- Solid Phase Extraction
Sample Analysis
- Hyphenated technique
- Chromatographic technique
- Electrophoresis
- Ligand Binding Assay
- Mass Spectrometry
- Nuclear Magnetic Resonance
Other Workflow

Bioanalytical Testing Service Market by Application

Market Overview
Oncology
Neurology
Infectious Diseases
Gastroenterology
Cardiology
Other Applications

Bioanalytical Testing Service Market by End User

Market Overview
Pharmaceutical and Biopharmaceutical Companies
Contract Development and Manufacturing Organizations (CDMO)
Contract Research Organizations (CRO)

Bioanalytical Testing Service Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Frontage Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intertek Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioanalytical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Almac Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anapharm (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmaron Beijing Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celerion (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioAgilytix Labs (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medpace Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioclinica (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LGC Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PSI CRO AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments